Beltsville, MD, USA – REPROCELL today announced the commercial launch of StemEdit, its clinical gene editing services and new gene-edited iPSC product lines leveraging OpenCRISPR-1™, an AI-designed genome editing system licensed from Profluent (Emeryville, CA, USA). StemEdit encompasses REPROCELL’s proprietary clinical gene-editing technology and its new gene-edited iPSC lines that are ready for immediate use. These offerings combine REPROCELL’s StemRNA™ […]
Dr. Hailing Shi to apply 3D spatial multi-omics to decode RNA regulation in the human brain and neurodegenerative diseases BOSTON — Stellaromics, a pioneer in high-resolution 3D spatial biology, today announced the installation of its Pyxa™ 3D spatial multi-omics system at Emory University School of Medicine. Emory becomes the third beta program site following successful deployments […]
New platform integrates epigenetic and transcriptomic analysis in a unified workflow, addressing key challenges in single-cell multi-omics research. LONDON, UK – SeekGene, a biotechnology company specializing in single-cell technology platforms, announced the launch of its novel high-throughput single-cell DNA methylation and RNA multi-omics solution at the Festival of Genomics & BioData 2026. The solution aims to […]
Adds Private Equity and Operational Experience to Help Scale iOrganBio’s Operations CHAPEL HILL, N.C. — iOrganBio, an innovator in intelligent cell manufacturing redefining how human cells are engineered and reliably produced at scale for research and therapy, including as New Approach Methodologies (NAMs) in alignment with FDA direction, today announced the appointment of Karol Jarzabek […]
Waters Corporation’s Q4 2025 Financial Results Conference Call will now be held on Monday, February 9th, 2026 at 8:30am ET in conjunction with the expected close of the transaction MILFORD, Mass. — Waters Corporation (NYSE: WAT) (the “Company” or “Waters”) today announced that, at the Company’s Special Meeting of Shareholders (the “Special Meeting”) held today, Waters […]
Expansion of iXCells’ iPSCore platform with integration of 3D human organoid expertise will enable evaluation of drug toxicity and tissue-specific responses Responds to growing demand for scalable, patient-relevant human models to support translational decision-making in drug development San Diego, CA: iXCells Biotechnologies (“iXCells”), a leading provider of human cell-based solutions and custom iPSC services, and Rosebud […]
Life sciences executive brings 20-plus years’ experience in biopharma and diagnostics, with precision oncology expertise STOCKHOLM — Pixelgen Technologies today announced the appointment of life sciences executive Nis Glavind Kruse as the company’s Chief Commercial Officer. Kruse will lead Pixelgen’s global commercial organization as the company accelerates adoption of its Pixelgen Proxiome Kit and new technologies enabling advanced protein interactomics research […]
Foster City, Calif. — Signios Bio today announced the launch of a new grant program supporting innovative spatial transcriptomics research using the 10x Genomics Xenium 5K Spatial Transcriptomics platform. The program is designed to enable U.S.-based researchers to generate high-plex, single-cell-resolution spatial gene expression data in human and mouse tissues. The Signios Bio Xenium 5K Spatial […]
SAN DIEGO, Calif. — BioTuring and 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a strategic collaboration to streamline and accelerate the path from data generation to biological insight for single cell and spatial research workflows. The collaboration connects 10x’s Chromium single cell platform and Xenium and Visium […]
VENLO, Netherlands — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that Mark Stevenson has been appointed as an independent member of the Supervisory Board as of January 23, 2026, and will stand for election at the next Annual General Meeting in June 2026. In addition, Prof. Dr. Ross Levine has stepped down from […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
